Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4K Buy
290
+200
+222% +$8.06K ﹤0.01% 1699
2026
Q1
$2.98K Sell
90
-37
-29% -$1.2K ﹤0.01% 2265
2025
Q4
$4.16K Sell
127
-45
-26% -$1.11K ﹤0.01% 2097
2025
Q3
$3.07K Buy
172
+116
+207% +$1.68K ﹤0.01% 2251
2025
Q2
$608 Buy
56
+28
+100% +$367 ﹤0.01% 2889
2025
Q1
$518 Hold
28
﹤0.01% 2860
2024
Q4
$461 Buy
+28
New +$396 ﹤0.01% 2921

Other funds holding AXGN

SBI Securities's AXGN Position: Q2 2026 in Review

SBI Securities increased its Axogen (AXGN) stake by 222% in Q2 2026, buying an estimated $8.06K and bringing the position to 290 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

SBI Securities first reported a position in AXGN in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • SBI Securities held 290 shares of Axogen worth $13.4K as of Q2 2026.
  • SBI Securities bought 200 Axogen shares in Q2 2026, an estimated $8.06K.
  • Axogen made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1699 holding.
  • SBI Securities first reported a position in Axogen in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.